Forendo Pharma Ltd Information

View Top Employees from Forendo Pharma Ltd

At Forendo, we are pioneering the translation of intracrinology science into first-in-class therapeutic solutions. Intracrinology enables us to address diseases on an unprecedented tissue specific level. Our lead clinical compound in endometriosis addresses a significant unmet need through its local effect on endometriotic lesions. Our second program is targeting polycystic ovarian syndrome (PCOS) which has no approved therapies. In addition to women’s health programs, Forendo has a strategic collaboration with Novartis leveraging our unique HSD17B platform in chronic liver diseases. We are based in Finland and backed by leading life science investors.

Website	http://www.forendo.com
Revenue	$5 million
Funding	$15.2 million
Employees	11 (3 on RocketReach)
Founded	2013
Address	IT INEN PITK KATU 4 B, Turku, Southwest Finland 20520, FI
Phone	+358 40 31080
Technologies	JavaScript , HTML , PHP +34 more (view full list)
Industry	Pharmaceuticals, Biotechnology, Health Care, Drug development, Healthcare, Medical, Drug Manufacturing & Research, Pharmaceutical
Web Rank	29 Million
Keywords	Clinical Development, Endometriosis Treatment, Targeted Therapies, First In Class Drugs, Hormone Replacement Therapy, Novel Drug Delivery, Innovative Medicines, Precision Medicine, Drug Discovery, Pharmaceutical Research, Biopharmaceutical Development, Therapeutic Solutions
Competitors	Genmab, Iovance Biotherapeutics, Inc., Lengo Therapeutics, Karyopharm Therapeutics Inc., Syndax Pharmaceuticals, Zymeworks Inc., Verastem Oncology, Medivir AB, Corvus Pharmaceuticals, OncoOne +40 more (view full list)
SIC	SIC Code 28 Companies, SIC Code 283 Companies
NAICS	NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies